The advanced Research & Development (R&D) Centre and pilot plant will soon be inaugurated at the four-acre campus of the Soujanya Group, a technologically advanced, international conglomerate with expertise in Colourants, Life Sciences, and Specialty Chemicals.

The construction of this state-of-the-art facility will adhere to the exacting "Current Good Manufacturing Practise" (cGMP) guidelines.

The R&D Center's main objective will be to speed up the creation of goods and procedures for Soujanya Lifesciences, a newly created division of the business that produces and distributes specialised Active Pharmaceutical Ingredients (APIs) and intermediates for the pharmaceutical and agrochemical industries.

The Soujanya Group, renowned for its technology-driven approach and innovative solutions, has set a new milestone in its pursuit of excellence with the inauguration of a state-of-the-art Research & Development (R&D) Center at its Navi Mumbai facility.

This cutting-edge center is poised to be a game-changer, empowering the conglomerate to develop more than six molecules concurrently and manufacture different volume products up to three-four MT per month.